Medtronic PLC closed 8.69% short of its 52-week high of $96.25, which the company reached on March 10th.

In the latest market close, Medtronic (MDT) reached $87.89, with a -1.09% movement compared to the previous day. The stock exceeded the S&P 500, which registered a loss of 4.84% for the day. Meanwhile ...

A U.S. appeals court has vacated a decision from the U.S. Patent and Trademark Office, reviving a spat between Recor Medical ...

Medtronic has issued a recall for several aortic root cannula devices due to a potential safety risk that could cause loose ...

Shares of Medtronic PLC MDT shed 1.52% to $88.49 Tuesday, on what proved to be an all-around mixed trading session for the ...

Medtronic (MDT) closed at $88.86 in the latest trading session, marking a +0.42% move from the prior day. This change lagged the S&P 500's 0.67% gain on the day. Meanwhile, the Dow experienced a rise ...

Medtronic's stock has lost around a third of its value since late 2022. However, stock prices for longtime dividend growers ...

Founded in 1993, The Motley Fool is a financial services company dedicated to making the world smarter, happier, and richer. The Motley Fool reaches millions of people every month through our premium ...

Medtronic has inked a neurovascular partnership with Methinks AI, a Barcelona, Spain-based developer of programs to detect ...

Atrial tachyarrhythmia recurred in 39 patients treated with Boston Scientific’s Farapulse PFA device, while 53 people had recurrence in the Medtronic cryoablation group.

Medtronic says its Evolut TAVR shows strong valve performance and durable outcomes at 5 years in low-risk aortic stenosis ...

Medtronic, Abbott and Boston Scientific provided updates on their devices used in heart valve disease treatment at the event.